XM does not provide services to residents of the United States of America.

In one year of war, Israel strikes 40,000 Hamas targets in Gaza



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>In one year of war, Israel strikes 40,000 Hamas targets in Gaza</title></head><body>

JERUSALEM, Oct 7 (Reuters) -In the past year in the Gaza Strip, Israel has bombed more than 40,000 targets, found 4,700 tunnel shafts and destroyed 1,000 rocket launcher sites, the military said on Monday's one-year anniversary of the Hamas-led militant attacks that triggered Israel's assault on the enclave.

Tallying troops whose names it received permission to publish, Israel's military said 726 Israeli soldiers had been killed since Oct. 7, 2023. Of those, 380 died in the Oct. 7 attacks and 346 in Gaza combat starting Oct. 27, 2023.

Injured troops numbered 4,576 since that date. Fifty-six soldiers died as a result of operational accidents, which the military did not define.

In data to mark the Oct. 7 anniversary, the Israeli military said it enlisted 300,000 reservists since the start of the war - 82% men and 18% women and nearly half of them aged 20 to 29.

Since the start of the war, 13,200 rockets were fired into Israel from Gaza. Another 12,400 were fired from Lebanon, while 60 came from Syria, 180 from Yemen and 400 from Iran, the military said.

It said it killed more than 800 "terrorists" in Lebanon, where 4,900 targets have been struck from the air along with about 6,000 ground targets. Over the past year, Israel arrested more than 5,000 suspects in the West Bank and Jordan Valley.

The military said it killed eight Gaza militant brigade commanders, about 30 battalion commanders and 165 company commanders over the past year.

The war in Gaza was triggered when Palestinian Hamas militants attacked southern Israel on Oct. 7, 2023, killing 1,200 people and taking about 250 as hostages, according to Israeli tallies. More than 100 hostages remain held by Hamas.

Israel's subsequent military assault on Gaza has killed nearly 42,000 Palestinians, according to Gaza's health ministry.



Reporting by Steven Scheer; Editing by Cynthia Osterman

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.